- Home
- BRKR vs CWAN Comparison
BRKR vs CWAN Comparison
Compare BRKR & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRKR | CWAN |
|---|---|---|
| Founded | 1960 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 7.1B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BRKR | CWAN |
|---|---|---|
| Price | $50.07 | $24.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $51.69 | $32.74 |
| AVG Volume (30 Days) | 2.3M | ★ 12.5M |
| Earning Date | 02-12-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.40% | N/A |
| EPS Growth | N/A | ★ 46826.67 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $3,438,900,000.00 | $640,376,000.00 |
| Revenue This Year | $3.58 | $64.94 |
| Revenue Next Year | $1.46 | $29.41 |
| P/E Ratio | ★ N/A | $17.26 |
| Revenue Growth | 6.10 | ★ 50.91 |
| 52 Week Low | $28.53 | $15.74 |
| 52 Week High | $60.09 | $32.00 |
Technical Indicators
Market Signals| Indicator | BRKR | CWAN |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 69.59 |
| Support Level | $46.82 | $24.05 |
| Resistance Level | $53.50 | $24.39 |
| Average True Range (ATR) | 2.56 | 0.10 |
| MACD | -0.25 | -0.12 |
| Stochastic Oscillator | 33.40 | 50.75 |
Price Performance
Historical ComparisonAbout BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.